-
Published 8/15/2025
Pagliaro JA, Wash LK, Ly K, Mathew J, Leibowitz A, Cabrera R, Wormwood JB, Vimalananda VG. Enrollment and Retention Outcomes from the Veterans Health Administration for a Remote Digital Health Study: Multisite Observational Study. JMIR Form Res. 2025 Aug 15; 9:e68676. PMID: 40334212.
-
Published 3/27/2025
Mathew J, Pagliaro JA, Elumalai S, Wash LK, Ly K, Leibowitz AJ, Vimalananda VG. Developing a Multisensor-Based Machine Learning Technology (Aidar Decompensation Index) for Real-Time Automated Detection of Post-COVID-19 Condition: Protocol for an Observational Study. JMIR Res Protoc. 2025 Mar 27; 14:e54993. PMID: 40146983.
-
Published 3/8/2025
Vimalananda VG, Kragen B, Leibowitz AJ, Qian S, Wormwood J, Linsky AM, Underwood P, Conlin PR, Kim B. Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providers. BMC Prim Care. 2025 Mar 08; 26(1):68. PMID: 40057678.
-
Published 9/26/2024
Abdellatif B, Natarajan V, Leibowitz AJ, Sitter KE, Vimalananda VG. Electronic Consultations for Endocrine Conditions: A Scoping Review. J Endocr Soc. 2024 Sep 26; 8(11):bvae170. PMID: 39403676.
-
Published 7/8/2024
Jasuja GK, Wolfe HL, Reisman JI, Vimalananda VG, Rao SR, Blosnich JR, Livingston NA, Shipherd JC. Corrigendum: Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations. Front Endocrinol (Lausanne). 2024; 15:1448887. PMID: 39040672.